214 related articles for article (PubMed ID: 20566715)
1. Allelic polymorphism in the T cell receptor and its impact on immune responses.
Gras S; Chen Z; Miles JJ; Liu YC; Bell MJ; Sullivan LC; Kjer-Nielsen L; Brennan RM; Burrows JM; Neller MA; Khanna R; Purcell AW; Brooks AG; McCluskey J; Rossjohn J; Burrows SR
J Exp Med; 2010 Jul; 207(7):1555-67. PubMed ID: 20566715
[TBL] [Abstract][Full Text] [Related]
2. A molecular basis for the interplay between T cells, viral mutants, and human leukocyte antigen micropolymorphism.
Liu YC; Chen Z; Neller MA; Miles JJ; Purcell AW; McCluskey J; Burrows SR; Rossjohn J; Gras S
J Biol Chem; 2014 Jun; 289(24):16688-98. PubMed ID: 24759101
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic T cell recognition of allelic variants of HLA B35 bound to an Epstein-Barr virus epitope: influence of peptide conformation and TCR-peptide interaction.
Khanna R; Silins SL; Weng Z; Gatchell D; Burrows SR; Cooper L
Eur J Immunol; 1999 May; 29(5):1587-97. PubMed ID: 10359113
[TBL] [Abstract][Full Text] [Related]
4. Natural micropolymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognition.
Archbold JK; Macdonald WA; Gras S; Ely LK; Miles JJ; Bell MJ; Brennan RM; Beddoe T; Wilce MC; Clements CS; Purcell AW; McCluskey J; Burrows SR; Rossjohn J
J Exp Med; 2009 Jan; 206(1):209-19. PubMed ID: 19139173
[TBL] [Abstract][Full Text] [Related]
5. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
Burrows SR; Silins SL; Khanna R; Burrows JM; Rischmueller M; McCluskey J; Moss DJ
Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis of a dominant T cell response to an HIV reverse transcriptase 8-mer epitope presented by the protective allele HLA-B*51:01.
Motozono C; Kuse N; Sun X; Rizkallah PJ; Fuller A; Oka S; Cole DK; Sewell AK; Takiguchi M
J Immunol; 2014 Apr; 192(7):3428-34. PubMed ID: 24600035
[TBL] [Abstract][Full Text] [Related]
7. TCR alpha genes direct MHC restriction in the potent human T cell response to a class I-bound viral epitope.
Miles JJ; Borg NA; Brennan RM; Tynan FE; Kjer-Nielsen L; Silins SL; Bell MJ; Burrows JM; McCluskey J; Rossjohn J; Burrows SR
J Immunol; 2006 Nov; 177(10):6804-14. PubMed ID: 17082594
[TBL] [Abstract][Full Text] [Related]
8. The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation.
Tynan FE; Elhassen D; Purcell AW; Burrows JM; Borg NA; Miles JJ; Williamson NA; Green KJ; Tellam J; Kjer-Nielsen L; McCluskey J; Rossjohn J; Burrows SR
J Exp Med; 2005 Nov; 202(9):1249-60. PubMed ID: 16275762
[TBL] [Abstract][Full Text] [Related]
9. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen.
Burrows SR; Silins SL; Moss DJ; Khanna R; Misko IS; Argaet VP
J Exp Med; 1995 Dec; 182(6):1703-15. PubMed ID: 7500015
[TBL] [Abstract][Full Text] [Related]
10. The flexibility of the TCR allows recognition of a large set of naturally occurring epitope variants by HIV-specific cytotoxic T lymphocytes.
Buseyne F; Rivière Y
Int Immunol; 2001 Jul; 13(7):941-50. PubMed ID: 11431424
[TBL] [Abstract][Full Text] [Related]
11. Biased T cell receptor usage directed against human leukocyte antigen DQ8-restricted gliadin peptides is associated with celiac disease.
Broughton SE; Petersen J; Theodossis A; Scally SW; Loh KL; Thompson A; van Bergen J; Kooy-Winkelaar Y; Henderson KN; Beddoe T; Tye-Din JA; Mannering SI; Purcell AW; McCluskey J; Anderson RP; Koning F; Reid HH; Rossjohn J
Immunity; 2012 Oct; 37(4):611-21. PubMed ID: 23063329
[TBL] [Abstract][Full Text] [Related]
12. Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance of virus-specific CTL responses.
Bihl F; Frahm N; Di Giammarino L; Sidney J; John M; Yusim K; Woodberry T; Sango K; Hewitt HS; Henry L; Linde CH; Chisholm JV; Zaman TM; Pae E; Mallal S; Walker BD; Sette A; Korber BT; Heckerman D; Brander C
J Immunol; 2006 Apr; 176(7):4094-101. PubMed ID: 16547245
[TBL] [Abstract][Full Text] [Related]
13. Structural modeling of HLA-B*1502/peptide/carbamazepine/T-cell receptor complex architecture: implication for the molecular mechanism of carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
Zhou P; Zhang S; Wang Y; Yang C; Huang J
J Biomol Struct Dyn; 2016 Aug; 34(8):1806-17. PubMed ID: 26488421
[TBL] [Abstract][Full Text] [Related]
14. Divergent T-cell receptor recognition modes of a HLA-I restricted extended tumour-associated peptide.
Chan KF; Gully BS; Gras S; Beringer DX; Kjer-Nielsen L; Cebon J; McCluskey J; Chen W; Rossjohn J
Nat Commun; 2018 Mar; 9(1):1026. PubMed ID: 29531227
[TBL] [Abstract][Full Text] [Related]
15. Structural features underlying T-cell receptor sensitivity to concealed MHC class I micropolymorphisms.
Stewart-Jones GB; Simpson P; van der Merwe PA; Easterbrook P; McMichael AJ; Rowland-Jones SL; Jones EY; Gillespie GM
Proc Natl Acad Sci U S A; 2012 Dec; 109(50):E3483-92. PubMed ID: 23161907
[TBL] [Abstract][Full Text] [Related]
16. Functional assays of HLA A2-restricted epitope variant of latent membrane protein 1 (LMP-1) of Epstein-Barr virus in nasopharyngeal carcinoma of Southern China and Taiwan.
Lin HJ; Cherng JM; Hung MS; Sayion Y; Lin JC
J Biomed Sci; 2005 Dec; 12(6):925-36. PubMed ID: 16307312
[TBL] [Abstract][Full Text] [Related]
17. Hierarchy of Epstein-Barr virus-specific cytotoxic T-cell responses in individuals carrying different subtypes of an HLA allele: implications for epitope-based antiviral vaccines.
Khanna R; Burrows SR; Neisig A; Neefjes J; Moss DJ; Silins SL
J Virol; 1997 Oct; 71(10):7429-35. PubMed ID: 9311821
[TBL] [Abstract][Full Text] [Related]
18. In vivo expansion of HLA-B35 alloreactive T cells sharing homologous T cell receptors: evidence for maintenance of an oligoclonally dominated allospecificity by persistent stimulation with an autologous MHC/peptide complex.
Steinle A; Reinhardt C; Jantzer P; Schendel DJ
J Exp Med; 1995 Feb; 181(2):503-13. PubMed ID: 7836907
[TBL] [Abstract][Full Text] [Related]
19. Impact of clonal competition for peptide-MHC complexes on the CD8+ T-cell repertoire selection in a persistent viral infection.
Wynn KK; Fulton Z; Cooper L; Silins SL; Gras S; Archbold JK; Tynan FE; Miles JJ; McCluskey J; Burrows SR; Rossjohn J; Khanna R
Blood; 2008 Apr; 111(8):4283-92. PubMed ID: 18270323
[TBL] [Abstract][Full Text] [Related]
20. T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide.
Tynan FE; Burrows SR; Buckle AM; Clements CS; Borg NA; Miles JJ; Beddoe T; Whisstock JC; Wilce MC; Silins SL; Burrows JM; Kjer-Nielsen L; Kostenko L; Purcell AW; McCluskey J; Rossjohn J
Nat Immunol; 2005 Nov; 6(11):1114-22. PubMed ID: 16186824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
